Annual Operating Profit
-$482.02 M
+$46.55 M+8.81%
31 December 2023
Summary:
Blueprint Medicines annual operaing income is currently -$482.02 million, with the most recent change of +$46.55 million (+8.81%) on 31 December 2023. During the last 3 years, it has risen by +$152.16 million (+23.99%). BPMC annual operating profit is now -256.14% below its all-time high of $308.71 million, reached on 31 December 2020.BPMC Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$48.97 M
-$5.93 M-13.77%
30 September 2024
Summary:
Blueprint Medicines quarterly operating income is currently -$48.97 million, with the most recent change of -$5.93 million (-13.77%) on 30 September 2024. Over the past year, it has increased by +$56.18 million (+53.43%). BPMC quarterly operating profit is now -107.73% below its all-time high of $633.37 million, reached on 30 September 2020.BPMC Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$276.00 M
+$78.23 M+22.09%
30 September 2024
Summary:
Blueprint Medicines TTM operating income is currently -$276.00 million, with the most recent change of +$78.23 million (+22.09%) on 30 September 2024. Over the past year, it has increased by +$206.03 million (+42.74%). BPMC TTM operating profit is now -181.50% below its all-time high of $338.65 million, reached on 30 June 2021.BPMC TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BPMC Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +53.4% | +42.7% |
| 3 y3 years | +24.0% | +84.3% | +56.5% |
| 5 y5 years | -33.4% | +29.4% | +23.6% |
BPMC Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +24.0% | -13.8% | +84.3% | at high | +60.1% |
| 5 y | 5 years | -256.1% | +24.0% | -107.7% | +84.3% | -181.5% | +60.1% |
| alltime | all time | -256.1% | +24.0% | -107.7% | +84.3% | -181.5% | +60.1% |
Blueprint Medicines Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$48.97 M(+13.8%) | -$276.00 M(-22.1%) |
| June 2024 | - | -$43.05 M(-45.4%) | -$354.23 M(-19.1%) |
| Mar 2024 | - | -$78.82 M(-25.0%) | -$437.93 M(-9.1%) |
| Dec 2023 | -$482.02 M(-8.8%) | -$105.15 M(-17.3%) | -$482.02 M(-8.2%) |
| Sept 2023 | - | -$127.21 M(+0.4%) | -$524.79 M(+0.9%) |
| June 2023 | - | -$126.75 M(+3.1%) | -$520.20 M(-5.2%) |
| Mar 2023 | - | -$122.91 M(-16.9%) | -$548.94 M(+3.9%) |
| Dec 2022 | -$528.57 M(-16.7%) | -$147.93 M(+20.6%) | -$528.57 M(-23.6%) |
| Sept 2022 | - | -$122.61 M(-21.1%) | -$692.25 M(+1.3%) |
| June 2022 | - | -$155.49 M(+51.6%) | -$683.46 M(+7.4%) |
| Mar 2022 | - | -$102.54 M(-67.1%) | -$636.48 M(+0.4%) |
| Dec 2021 | -$634.18 M(-305.4%) | -$311.60 M(+173.8%) | -$634.18 M(+55.2%) |
| Sept 2021 | - | -$113.83 M(+4.9%) | -$408.54 M(-220.6%) |
| June 2021 | - | -$108.51 M(+8.3%) | $338.65 M(+5.1%) |
| Mar 2021 | - | -$100.24 M(+16.6%) | $322.13 M(+4.3%) |
| Dec 2020 | $308.71 M(-185.4%) | -$85.97 M(-113.6%) | $308.71 M(-5.1%) |
| Sept 2020 | - | $633.37 M(-606.5%) | $325.29 M(-180.1%) |
| June 2020 | - | -$125.04 M(+10.0%) | -$406.03 M(+5.5%) |
| Mar 2020 | - | -$113.66 M(+63.8%) | -$384.91 M(+6.5%) |
| Dec 2019 | -$361.33 M | -$69.38 M(-29.2%) | -$361.33 M(-3.7%) |
| Sept 2019 | - | -$97.96 M(-5.7%) | -$375.09 M(+6.4%) |
| June 2019 | - | -$103.91 M(+15.4%) | -$352.64 M(+26.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$90.07 M(+8.3%) | -$278.19 M(+12.6%) |
| Dec 2018 | -$247.03 M(+63.3%) | -$83.14 M(+10.1%) | -$247.03 M(+15.4%) |
| Sept 2018 | - | -$75.51 M(+156.2%) | -$213.98 M(+20.8%) |
| June 2018 | - | -$29.47 M(-50.0%) | -$177.08 M(-2.6%) |
| Mar 2018 | - | -$58.91 M(+17.6%) | -$181.83 M(+20.2%) |
| Dec 2017 | -$151.25 M(+108.4%) | -$50.09 M(+29.7%) | -$151.25 M(+23.4%) |
| Sept 2017 | - | -$38.61 M(+12.8%) | -$122.53 M(+21.6%) |
| June 2017 | - | -$34.21 M(+20.8%) | -$100.80 M(+17.9%) |
| Mar 2017 | - | -$28.33 M(+32.6%) | -$85.48 M(+17.8%) |
| Dec 2016 | -$72.58 M(+40.5%) | -$21.37 M(+26.6%) | -$72.58 M(+8.9%) |
| Sept 2016 | - | -$16.88 M(-10.7%) | -$66.62 M(+7.1%) |
| June 2016 | - | -$18.90 M(+22.5%) | -$62.22 M(+11.7%) |
| Mar 2016 | - | -$15.43 M(+0.0%) | -$55.72 M(+7.9%) |
| Dec 2015 | -$51.64 M(+30.0%) | -$15.42 M(+23.6%) | -$51.64 M(+2.2%) |
| Sept 2015 | - | -$12.48 M(+0.7%) | -$50.52 M(+4.5%) |
| June 2015 | - | -$12.40 M(+9.2%) | -$48.33 M(+9.5%) |
| Mar 2015 | - | -$11.35 M(-20.6%) | -$44.13 M(+11.1%) |
| Dec 2014 | -$39.73 M(+89.2%) | -$14.29 M(+38.9%) | -$39.73 M(+56.2%) |
| Sept 2014 | - | -$10.29 M(+25.5%) | -$25.44 M(+67.9%) |
| June 2014 | - | -$8.20 M(+17.9%) | -$15.15 M(+117.9%) |
| Mar 2014 | - | -$6.95 M | -$6.95 M |
| Dec 2013 | -$21.00 M | - | - |
FAQ
- What is Blueprint Medicines annual operaing income?
- What is the all time high annual operating profit for Blueprint Medicines?
- What is Blueprint Medicines quarterly operating income?
- What is the all time high quarterly operating profit for Blueprint Medicines?
- What is Blueprint Medicines quarterly operating profit year-on-year change?
- What is Blueprint Medicines TTM operating income?
- What is the all time high TTM operating profit for Blueprint Medicines?
- What is Blueprint Medicines TTM operating profit year-on-year change?
What is Blueprint Medicines annual operaing income?
The current annual operating profit of BPMC is -$482.02 M
What is the all time high annual operating profit for Blueprint Medicines?
Blueprint Medicines all-time high annual operaing income is $308.71 M
What is Blueprint Medicines quarterly operating income?
The current quarterly operating profit of BPMC is -$48.97 M
What is the all time high quarterly operating profit for Blueprint Medicines?
Blueprint Medicines all-time high quarterly operating income is $633.37 M
What is Blueprint Medicines quarterly operating profit year-on-year change?
Over the past year, BPMC quarterly operating income has changed by +$56.18 M (+53.43%)
What is Blueprint Medicines TTM operating income?
The current TTM operating profit of BPMC is -$276.00 M
What is the all time high TTM operating profit for Blueprint Medicines?
Blueprint Medicines all-time high TTM operating income is $338.65 M
What is Blueprint Medicines TTM operating profit year-on-year change?
Over the past year, BPMC TTM operating income has changed by +$206.03 M (+42.74%)